Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

Table 2

AAV-Tβ4 alleviates increases in MDA content and MPO activity in heart tissues.

	MDA	(nmol/mg protein)	MPO	(U/mg protein)
	Day 7	Day 42	Day 7	Day 42
NS	0.71 ± 0.66 (n = 7)	0.82 ± 0.36 (n = 7)	0.48 ± 0.42 (n = 7)	0.66 ± 0.25 (n = 7)
AMI	1.45 ± 0.43 (n = 7)	1.88 ± 0.85 (n = 4)	0.92 ± 0.23 (n = 7)	1.27 ± 0.89 (n = 4)
AMI+AAV-LacZ	1.48 ± 0.33 (n = 7)	1.97 ± 0.86 (n = 5)	0.89 ± 0.35 (n = 7)	1.12 ± 0.93 (n = 5)
AMI+AAV-Tβ4	0.91 ± 0.27 (n = 7)	1.18 ± 0.41 (n = 6)	0.55 ± 0.12 (n = 7)	0.78 ± 0.23 (n = 6)

P<0.05 vs the AMI or AMI+AAV-LacZ group.